Structural Heart Imaging Market is Projected to Reach US$ 32.2 Billion by 2028, With 10.2% CAGR

IMARC Group, a leading market research company, has recently releases report titled "Structural Heart Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028."

How Big is the Structural Heart Imaging market?

The global structural heart imaging market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.2 Billion by 2028, exhibiting a growth rate (CAGR) of 10.2% during 2023-2028.

Request Your free sample copy of this report: https://www.imarcgroup.com/structural-heart-imaging-market/requestsample

Structural heart imaging comprises a wide variety of procedures, such as valvuloplasty, annuloplasty, left atrial appendage closure (LAAC), transcatheter mitral valve repair (TMVR), and surgical aortic valve replacement (SAVR), which involves removing a damaged valve and replacing it with a new one made from synthetic materials or animal tissue. It also consists of transcatheter aortic valve replacement (TAVR), which has progressed from being approved for high-risk patients to all groups of patients currently.

It involves the employment of trans-esophageal echocardiogram, cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI), and 3D intracardiac echocardiography, which provides real-time visualization in various interventional scenarios. Structural heart imaging is an essential tool for evaluating several parameters while planning the correct procedure, such as the health conditions of the patient, patient compatibility with the procedure, presence of enough landing zone for the device, risks for procedural complications, and the appropriate size of the device. It is a unique technique that is utilized to acquire a picture of the heart, blood vessels, and surrounding tissues for the examination and screening of the heart. It is also employed for treating a condition named aortic stenosis, which causes the narrowing of the aortic valve and blockage in the flow of blood.

What are the growth prospects and trends in the structural heart imaging Industry?

At present, the increasing demand for structural heart imaging for the treatment and analysis of heart blockages represents one of the primary factors influencing the market positively. Besides this, the rising occurrence of various congenital cardiovascular diseases, such as ventricular septal defect (VSD), atrial septal defect, coarctation of the aorta, Ebstein Anomaly, interrupt4ed aortic arch, double-outlet right ventricle, and hypoplastic left heart syndrome, is propelling the growth of the market.

In addition, the growing prevalence of various chronic ailments, such as obesity, thyroiditis, and diabetes, due to the adoption of unhealthy lifestyle habits and consumption of high-calorie diets is offering a favorable market outlook. Apart from this, the rising preferences of individuals to opt for minimally invasive surgical methods to treat various heart conditions, as they minimize post-operative scarring, reduce the duration of hospital stay, and prevent excessive expenditures, are contributing to the growth of the market.

Additionally, the increasing incidence of stroke and heart attacks among the masses induced by anxiety and excessive stress is supporting the growth of the market. Moreover, the rising advancements in magnetic resonance imaging (MRI) techniques, such as magnetic resonance (MR) spectroscopy, perfusion, functional MRI, and diffusion tensor imaging, are strengthening the growth of the market. Furthermore, the increasing fusion of various imaging modalities to generate high-quality images is bolstering the growth of the market.

Inquiry Before Buying : https://www.imarcgroup.com/request?type=report&id=5127&flag=F

What is included in market segmentation?

Breakup by Imaging Modality:
• Echocardiogram
• Angiogram
o CT
o MRI

Breakup by Procedure Type:
• Transcatheter Aortic Valve Replacement (TAVR)
• Surgical Aortic Valve Replacement (SAVR)
• Transcatheter Mitral Valve Repair (TMVR)
• Left Atrial Appendage Closure (LAAC)
• Annuloplasty
• Valvuloplasty
• Others

Breakup by Application:
• Diagnosis
• Surgery

Breakup by End User:
• Hospitals
• Specialty Clinics
• Cardiac Centers
• Diagnostic Centers
• Ambulatory Surgical Centers
• Catheterization Laboratories
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5127&flag=C

Who are the key players operating in the industry?

The report covers the major market players including:

Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.